Home › Rectal Cancer › Arizona › Phoenix
Rectal Cancer clinical trials in Phoenix, AZ
6 studies for Rectal Cancer are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RecruitingHealthy volunteers welcome
- Cancer Center at Saint Joseph's, Phoenix
Family Communications After Genetic Testing
RecruitingHealthy volunteers welcome
- Cancer Center at Saint Joseph's, Phoenix
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
RecruitingPhase 3
- Mayo Clinic - Arizona ( Site 0090), Phoenix
PRE-ISPY Phase I/II Oncology Platform Program
RecruitingPhase 1/2
- Mayo Clinic Comprehensive Cancer Center, Phoenix
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Recruiting
- Cancer Center at Saint Joseph's, Phoenix
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
RecruitingPhase 3
- Cancer Center at Saint Joseph's, Phoenix
Rectal Cancer trials in other cities
- New York City, NY17 studies
- Boston, MA12 studies
- Houston, TX11 studies
- St. Louis, MO11 studies
- Los Angeles, CA10 studies
- Columbus, OH10 studies
- Tampa, FL9 studies
- Seattle, WA9 studies
- Nashville, TN9 studies
- Rochester, MN8 studies
- Chicago, IL8 studies
- Aurora, CO8 studies
Other studies in Phoenix
- Breast Cancer25 studies
- Colorectal Cancer25 studies
- Obesity22 studies
- Non-Small Cell Lung Cancer20 studies
- Metastatic Cancer20 studies
- Heart Failure18 studies
- Prostate Cancer17 studies
- Cancer (all types)17 studies
- Multiple Myeloma16 studies
- Pancreatic Cancer16 studies
- Cardiovascular Disease16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.